Rosen DG - Search Results

1

Activation of BTAK expression in primary ovarian surface epithelial cells of prophylactic ovaries.

Zhang Z, Singh M, Davidson S, Rosen DG, Yang G, Liu J. Zhang Z, et al. Among authors: rosen dg. Mod Pathol. 2007 Oct;20(10):1078-84. doi: 10.1038/modpathol.3800945. Epub 2007 Aug 3. Mod Pathol. 2007. PMID: 17673924 Free article.

2

Validation of tissue microarray technology in ovarian carcinoma.

Rosen DG, Huang X, Deavers MT, Malpica A, Silva EG, Liu J. Rosen DG, et al. Mod Pathol. 2004 Jul;17(7):790-7. doi: 10.1038/modpathol.3800120. Mod Pathol. 2004. PMID: 15073602 Free article.

3

Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.

Cai KQ, Albarracin C, Rosen D, Zhong R, Zheng W, Luthra R, Broaddus R, Liu J. Cai KQ, et al. Hum Pathol. 2004 May;35(5):552-9. doi: 10.1016/j.humpath.2003.12.009. Hum Pathol. 2004. PMID: 15138928

4

Lessons from border cell migration in the Drosophila ovary: A role for myosin VI in dissemination of human ovarian cancer.

Yoshida H, Cheng W, Hung J, Montell D, Geisbrecht E, Rosen D, Liu J, Naora H. Yoshida H, et al. Proc Natl Acad Sci U S A. 2004 May 25;101(21):8144-9. doi: 10.1073/pnas.0400400101. Epub 2004 May 14. Proc Natl Acad Sci U S A. 2004. PMID: 15146066 Free PMC article.

5

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.

Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, Smith D, Hartmann L, Fishman D, Berchuck A, Schmandt R, Whitaker R, Gershenson DM, Mills GB, Bast RC Jr. Lu KH, et al. Among authors: rosen dg. Clin Cancer Res. 2004 May 15;10(10):3291-300. doi: 10.1158/1078-0432.CCR-03-0409. Clin Cancer Res. 2004. PMID: 15161682

6

Telomerase in breast cancer: a critical evaluation.

Baykal A, Rosen D, Zhou C, Liu J, Sahin AA. Baykal A, et al. Adv Anat Pathol. 2004 Sep;11(5):262-8. doi: 10.1097/01.pap.0000138145.19258.64. Adv Anat Pathol. 2004. PMID: 15322492 Review.

7

Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.

Rosen DG, Wang L, Jain AN, Lu KH, Luo RZ, Yu Y, Liu J, Bast RC Jr. Rosen DG, et al. Clin Cancer Res. 2004 Oct 1;10(19):6559-66. doi: 10.1158/1078-0432.CCR-04-0698. Clin Cancer Res. 2004. PMID: 15475444

8

Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer.

Rosen DG, Yang G, Cai KQ, Bast RC Jr, Gershenson DM, Silva EG, Liu J. Rosen DG, et al. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):632-7. Clin Cancer Res. 2005. PMID: 15701850

9

Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer.

Lee P, Rosen DG, Zhu C, Silva EG, Liu J. Lee P, et al. Among authors: rosen dg. Gynecol Oncol. 2005 Mar;96(3):671-7. doi: 10.1016/j.ygyno.2004.11.010. Gynecol Oncol. 2005. PMID: 15721410

10

Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract.

Cheng W, Liu J, Yoshida H, Rosen D, Naora H. Cheng W, et al. Nat Med. 2005 May;11(5):531-7. doi: 10.1038/nm1230. Epub 2005 Apr 10. Nat Med. 2005. PMID: 15821746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page